FDA staff reports suggest the agency might want to rethink those approvals in light of new evidence the drugs' efficacy is limited to certain subgroups that can be defined by PD-L1 expression.
Neuralink, the medical technology company founded by Elon Musk, received an important clearance from the Food and Drug Administration that may allow the brain implant system to help people with ...
Last year, the FDA approved Eli Lilly’s CDK4/6 inhibitor, abemaciclib or Verzenio, for use in stage 2 and 3 HR positive, HER2 negative breast cancer, but not for breast cancers that had not yet ...